Ghost Tree Capital, LLC Aeglea Bio Therapeutics, Inc. Transaction History

Ghost Tree Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.35 - $1.54 $70,000 - $308,000	-200,000 Reduced 20.0%	800,000 $360,000
Q3 2022 Nov 14, 2022	BUY	$0.38 - $0.81 $28,500 - $60,750	75,000 Added 8.11%	1,000,000 $526,000
Q2 2022 Aug 15, 2022	BUY	$0.5 - $2.66 $119,200 - $634,146	238,401 Added 34.72%	925,000 $467,000
Q1 2022 May 16, 2022	BUY	$1.87 - $4.77 $1.28 Million - $3.28 Million	686,599 New	686,599 $1.58 Million

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.